About the Center for Neuroinflammation and Cardiometabolic Diseases (CNCD)
Our mission is to promote interdisciplinary research in neuroinflammation, which is recognized as a common factor in the development of diseases ranging from hypertension and obesity to Alzheimer’s disease and depression. Faculty from diverse backgrounds collaborate to improve scientific understanding of the mechanisms of neuroinflammation—findings that will have important clinical implications in the diagnosis and treatment of these diseases.
Vasopressin Casts Light on the Suprachiasmatic Nucleus
In a recently published work in the Journal of Physiology, Professor Mike Ludwig and team of international colleagues discovered a new intrinsic vasopressin system within the eye that projects to our biological clock, the suprachiasmatic nucleus (SCN), being a major player in light-evoked physiological and behavioral rhythms.
An internationally recognized researcher in autonomic and neuroendocrine neuroscience, Dr. Javier Stern is the founding director of the Center for Neuroinflammation and Cardiometabolic Diseases.